We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DOJ PROBING PFIZER SALES PRACTICES; LILLY SAYS ZYPREXA MAY BE NEXT
DOJ PROBING PFIZER SALES PRACTICES; LILLY SAYS ZYPREXA MAY BE NEXT
March 11, 2004
The Justice Department has launched a formal probe into Pfizer’s sales practices for two products that account for more than $1 billion in annual U.S. sales, the firm has announced in a regulatory filing.